In contrast, PGRMC1 was significantly elevated in serous papillary adenocarcinoma (p = 4 × 10−5), papillary serous cystadenocarcinoma (Figure 1(h), p = 0.006) and endometroid carcinoma (p = 0.02, Supplemental Figure 2). This evidence concerns the gene PGRMC1 and papillary serous cystadenocarcinoma.